EP 1049485 A1 20001108 - ENHANCEMENT OF HEMATOPOIETIC CELLS
Title (en)
ENHANCEMENT OF HEMATOPOIETIC CELLS
Title (de)
STEIGERUNG DER HEMATOPOIETISCHEZELLEN
Title (fr)
STIMULATION DE CELLULES HEMATOPOIETIQUES
Publication
Application
Priority
- US 9800887 W 19980120
- US 3587597 P 19970121
Abstract (en)
[origin: WO9831385A1] The invention relates to a method for enhancing hematopoiesis by contacting hematopoietic stem or progenitor cells with a composition containing prolactin. Preferably the prolactin used is recombinant prolactin. Stimulation of hematopoesis can serve to replace hematopoietic cells as they become ablated because of a therapeutic drug or treatment. The enhancement can also function to recruit new or additional cell lineages to a depleted or poorly-functional repertoire of cells. The invention further relates to a method for treating an animal to improve hematopoiesis or prevent hematopoietic-suppresion by administering a pharmaceutically acceptable composition containing prolactin. The invention further relates to a composition comprising a cytokine that can enhance hematopoiesis and prolactin. The invention further relates to a composition comprising a therapeutic that can cause hematopoietic-suppresion and a prolactin.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/22 (2006.01); A61P 7/00 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 38/2257 (2013.01); A61P 7/00 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 9831385A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9831385 A1 19980723; AU 6028298 A 19980807; CA 2277482 A1 19980723; EP 1049485 A1 20001108; JP 2001516341 A 20010925
DOCDB simple family (application)
US 9800887 W 19980120; AU 6028298 A 19980120; CA 2277482 A 19980120; EP 98903533 A 19980120; JP 53457898 A 19980120